Aim The pathophysiology of insulin resistance (IR) comprises a complex adipokine
mediated cross-talk between white adipose tissue and other organs. Dipeptidyl peptidase-4 …

Abstract Objectives Dipeptidyl peptidase-4 (DPP4) was recently proposed as a novel
adipokine linked to insulin resistance (IR). As IR represents a cluster of disorders in hepatic …

Aims The inability of kidneys to prevent urinary protein leakage represents the earliest sign
of renal damage in diabetic kidney disease (DKD). Recent data suggest the possible …

Aims Currently, inhibition of dipeptidyl peptidase-4 (DPP-4) is widely used in the treatment of
type 2 diabetes. Application of this strategy is awaited as a new therapeutic approach for …

Aim: Dipeptidyl peptidase (DPP)‐4 in responsible for incretin degradation and some
observations suggest that DPP‐4 activity is increased in type 2 diabetes (T2D). We aimed to …

Background. The enzyme dipeptidyl peptidase 4 (DPP4) has been recently recognized as
an adipo‐myokine. However, studies that associate its constitutive activity with body …

Background: Dipeptidyl peptidase-4 (DPP-4) is strongly expressed in the kidney, and
soluble levels of this protein are used as a marker in various chronic inflammatory diseases …

Background: Increase in circulating dipeptidyl peptidase-4 (DPP4) activity and levels has
been reported to associate both with hyperglycemia and obesity. Here we aim to decipher …

Dipeptidyl peptidase-4 (DPP-4) has an important role in the carbohydrate metabolism with
the degradation of incretin hormones. Aim: We assessed the serum DPP-4 activity both in …

Aim To evaluate circulating plasma dipeptidyl peptidase-4 (DPP4) levels in non-obese
Asian Indians with type 2 diabetes mellitus (T2DM), and to correlate these with metabolic …